Victoza 6 mg/mL – 2-Pen Pack

Description

Victoza 6 mg is a once-daily injectable GLP-1 receptor agonist containing liraglutide, designed to help individuals with Type 2 diabetes control blood sugar and support long-term weight management. This 2-pen pack offers a convenient supply for ongoing treatment and is widely prescribed for its cardiovascular protection, A1C reduction, and appetite suppression.

💉 Key Features of Victoza 6 mg

• Each pen contains 18 mg of liraglutide in 3 mL (6 mg/mL concentration)

• Adjustable dose options: 0.6 mg, 1.2 mg, or 1.8 mg per day

• Two prefilled injection pens included per pack

• Once-daily injection with a discreet, easy-to-use pen

• FDA-approved for Type 2 diabetes and cardiovascular risk reduction

📦 What’s Included

• 2 x Victoza 6 mg/mL prefilled pens (each delivers multiple doses)

• Compatible pen needles (if included by pharmacy)

• Full prescribing and usage instructions

• Shipped in temperature-controlled packaging

🩺 How Victoza Works

Victoza mimics the GLP-1 hormone, which:

• Stimulates insulin release only when blood sugar is high

• Reduces glucagon secretion to prevent excess sugar in the blood

• Slows gastric emptying, helping with appetite control and weight loss

• Improves cardiovascular health and reduces risk of major heart events

⚖️ Clinical Benefits

• Proven to lower HbA1c (A1C) levels

• Effective weight loss support, especially at higher doses

• Reduces the risk of heart attack, stroke, and death in high-risk individuals

• Complements oral diabetes medications or insulin therapy

🕒 Dosage & Usage

• Start at 0.6 mg daily for 1 week

• Increase to 1.2 mg, then potentially to 1.8 mg, depending on physician guidance

• Inject subcutaneously in the abdomen, thigh, or upper arm

• Administer once daily, at any time of day, with or without food

• Each pen contains up to 30 doses at 0.6 mg, fewer if higher doses are used

⚠️ Safety Information

• Do not use if you or a family member have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Not approved for Type 1 diabetes or diabetic ketoacidosis

• Common side effects: nausea, vomiting, diarrhea, constipation, headache, and indigestion

• May increase risk of pancreatitis, kidney problems, or gallbladder issues

• Not recommended during pregnancy or breastfeeding

❄️ Storage Instructions

• Before use: Refrigerate (36°F to 46°F / 2°C to 8°C)

• After first use: Store at room temperature (up to 86°F / 30°C) or refrigerated; discard after 30 days

• Do not freeze. Keep pens capped and away from direct sunlight

❓ Frequently Asked Questions

Q: How long does each pen last?
A: This depends on your daily dose:

• At 0.6 mg/day: ~30 doses per pen

• At 1.2 mg/day: ~15 doses per pen

• At 1.8 mg/day: ~10 doses per pen

Q: Is Victoza the same as Saxenda?
A: Both contain liraglutide, but Victoza is approved for Type 2 diabetes, while Saxenda is approved for weight management. The dosing and branding differ.

Q: Can Victoza help with weight loss?
A: Yes, many users report moderate to significant weight loss due to appetite suppression, especially at higher doses.

Q: Are needles included?
A: This depends on the pharmacy. Some include compatible pen needles, while others require you to purchase them separately.

Q: Is Victoza an insulin drug?
A: No. Victoza is not insulin, but a GLP‑1 receptor agonist (liraglutide)—a class of medication that mimics the natural hormone GLP‑1 to help control blood sugar and reduce appetite. It is used in adults and children aged 10 and older with type 2 diabetes, alongside diet and exercise

Q: What happens when you stop taking Victoza?
A: When you stop taking Victoza (liraglutide), your blood sugar levels may increase, potentially leading to hyperglycemia (high blood sugar). It’s crucial to consult with a healthcare professional before discontinuing Victoza, as they may need to adjust your other diabetes medications. Stopping abruptly could also cause nausea that lasts for a few days.